Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
紐約, Aug. 11, 2022 (GLOBE NEWSWIRE) -- 正在代表 17 Education & Technology Group Inc. (「17 E&T」或「公司」) (NASDAQ: YQ) 的投資者調查索償事宜。 建議此類投資者聯絡 Robert S. Willoughby，電郵：newaction@pomlaw.com...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Robert...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centessa Pharmaceutical plc (“”CNTA” or the “Company”) (NASDAQ: CNTA). Such investors...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 17 Education & Technology Group Inc. (“17 E&T” or the “Company”) (NASDAQ: YQ). ...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM). Such investors are...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Carvana Co. (“Carvana” or the “Company”) (NYSE: CVNA). Such investors are advised to...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Weber Inc. (“”Weber” or the “Company”) (NYSE: WEBR). Such investors are advised to...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Missfresh Limited (“Missfresh” or the “Company”) (NASDAQ: MF). Such investors are...
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Inotiv, Inc. - NOTV
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (“Inotiv” or the “Company”) (NASDAQ: NOTV). Such investors are advised to...
-
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ: TGTX) and...